Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 3, 2015
[Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis]Xiangzong Zeng, Na Wei, Yi'ni Wang, et al.
Clinical Science (London, England : 1979)|May 28, 2026
SIRPA ablation inhibits intimal hyperplasia by promoting PPARγ-regulated alternative macrophage polarizationTao He, Xiaoyan Wu, Quan Zhang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 20, 2024
Tumor necrosis factor receptor-associated factor 5 protects against intimal hyperplasia by regulation of macrophage polarization via directly targeting PPARγWen-Lin Cheng, Sheng-Ping Chao, Fang Zhao, et al.
Redox Biology|June 24, 2023
Leucine zipper protein 1 prevents doxorubicin-induced cardiotoxicity in miceDi Fan, Zhili Jin, Jianlei Cao, et al.
BMC Infectious Diseases|November 21, 2025
Safety, immunogenicity, persistence and dose evaluation of the CS-2034 mRNA COVID-19 vaccine: a phase II randomized controlled trial in healthy Chinese adultsZhili Jin, Jingxuan Wu, Tao Huang, et al.
British Journal of Pharmacology|February 23, 2026
Development of a novel tyrosine kinase 2 inhibitor ARTS-011 and its first-in-human single and multiple ascending dose Phase I study to evaluate the tolerability, safety, pharmacokinetic profile and food effectsZhili Jin, Jingxuan Wu, Jiaqi Liang, et al.
The Journal of Infection|October 28, 2023
Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adultsZhili Jin, Jingxuan Wu, Ying Wang, et al.
Pageof 3